ADSCaN: a randomised phase ii study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC)

Lawless, C., Boyd, K., Faivre-Finn, C. et al. (9 more authors) (2018) ADSCaN: a randomised phase ii study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). In: Lung Cancer. The 16th Annual British Thoracic Oncology Group Conference 2018, 24-26 Jan 2018, Dublin . Elsevier , S88-S89.

Metadata

Authors/Creators:
  • Lawless, C.
  • Boyd, K.
  • Faivre-Finn, C.
  • Fenwick, J.
  • Haswell, T.
  • Landau, D.
  • Lester, J.
  • McCartney, E.
  • Paul, J.
  • Shaw, A.
  • Simoes, R.
  • Hatton, M.O.
Copyright, Publisher and Additional Information: © 2018 Elsevier. This is an author produced version of a paper subsequently published in Lung Cancer. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Dates:
  • Published: January 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 17 May 2018 09:06
Last Modified: 01 Feb 2019 01:49
Published Version: https://doi.org/10.1016/S0169-5002(18)30224-1
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/S0169-5002(18)30224-1
Related URLs:

Share / Export

Statistics